Show simple item record

dc.contributor.authorFarup, Per Grønaas
dc.contributor.authorLydersen, Stian
dc.contributor.authorValeur, Jørgen
dc.date.accessioned2020-02-11T09:08:10Z
dc.date.available2020-02-11T09:08:10Z
dc.date.created2019-10-01T20:28:34Z
dc.date.issued2019
dc.identifier.citationJournal of Obesity. 2019, 2019 1-8.nb_NO
dc.identifier.issn2090-0708
dc.identifier.urihttp://hdl.handle.net/11250/2640931
dc.description.abstractObesity has been associated with changes in the gut microbiota and its metabolites. The study explored changes in the faecal microbiota and short-chain fatty acids (SCFA) associated with the diet (including nonnutritive sweeteners (NNSs)) and evaluated metabolic consequences in subjects with morbid obesity. The diet was assessed with a validated food frequency questionnaire. One unit of NNSs was 100 mL beverage with NNSs or 2 tablets/teaspoons of NNSs. The faecal microbiota was assessed with GA-map® dysbiosis test and SCFA with gas chromatography and flame ionisation detection. Fourteen men and 75 women with a mean age of 44.6 (SD 8.7) years, BMI 41.8 (SD 3.6) kg/m2, and intake of NNSs 7.5 units/day (SD 3.2; range 0-43) were included. Faecal butyric acid was positively and negatively associated with the intake of starch (partial correlation = 0.264; p=0.015) and NNSs (partial correlation = -0.274; p=0.011), respectively. NNSs were associated with changes in four out of 39 bacterial groups. Butyric acid has antiobesogenic effects, reduces insulin resistance, and improves dyslipidaemia. Since the weight-reducing effect of NNSs on obese adults trying to lose weight is dubious, it seems imprudent to use NNSs that might counteract the favourable effects of butyric acid.nb_NO
dc.language.isoengnb_NO
dc.publisherHindawinb_NO
dc.relation.urihttp://downloads.hindawi.com/journals/jobe/2019/4608315.pdf
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleAre Nonnutritive Sweeteners Obesogenic? Associations between Diet, Faecal Microbiota, and Short-Chain Fatty Acids in Morbidly Obese Subjectsnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber1-8nb_NO
dc.source.volume2019nb_NO
dc.source.journalJournal of Obesitynb_NO
dc.identifier.doi10.1155/2019/4608315
dc.identifier.cristin1732740
dc.description.localcodeCopyright© 2019 Per G. Farup et al. )is is an open access article distributed under the Creative Commons Attribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly citenb_NO
cristin.unitcode194,65,15,0
cristin.unitcode194,65,35,5
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.unitnameRKBU Midt-Norge - Regionalt kunnskapssenter for barn og unge - psykisk helse og barnevern
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Navngivelse 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Navngivelse 4.0 Internasjonal